Korea vs Uruguay: The number of people with susceptibility test result for rifampicin
Korea
82.06
in 2021
Uruguay
80.19
in 2021
Korea rank
91st
Uruguay rank
93rd
The number of people with susceptibility test result for rifampicin over time
- Korea
- Uruguay
How they compare
Korea currently reports 82.06 against 80.19 in Uruguay, a difference of 1.87.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Uruguay ahead.
Korea ranks 91st and Uruguay ranks 93rd of 146 countries.
Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Korea | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 84.51 | 83.76 | 0.7502 | Korea |
| 2020s | 85.46 | 80.16 | 5.3 | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Korea or Uruguay?
- Korea, at 82.06 against 80.19 in Uruguay as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Korea and Uruguay?
- 1.87, with Korea ahead.
- How many years of comparable data are there for Korea and Uruguay?
- 5 years are reported by both, from 2017 to 2021.
- How do Korea and Uruguay rank globally for the number of people with susceptibility test result for rifampicin?
- Korea ranks 91st and Uruguay ranks 93rd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.